Vial
San Francisco, United States · Founded 2020 · $34.0M raised
- Headquarters
- San Francisco, California
- Employees
- 51–200
- Founded
- 2020
- Business Model
- B2B
- Website
- vial.com
- Total Funding
- $34.0M
- Last Round
- $34.0M Series BNov 2022
- Rounds
- 5
About
Next-generation pharma company using computationally designed therapeutics and automated clinical trials to advance RNA, antibody, and small-molecule programs.
Summary
Vial is a Life Sciences company based in San Francisco, United States, founded in 2020. It has raised $34.0M in total across 5 rounds, most recently a $34.0M Series B round in Nov 2022. Investors include Buckley Ventures, General Catalyst and Andreessen Horowitz.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Nov 2022
Sign up to see all 5 rounds
Seed through Series B — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
Altos Labs combines academic science and industry development to create medicines that restore ce...
BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Calico researches human aging using advanced technologies and model systems, applying that knowle...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/vial"><img src="https://indexed.vc/api/badge/company/vial" alt="Vial on Indexed.vc" width="260" height="76" /></a>